Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation

about

Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation

Item

http://www.wikidata.org/entity/Q36418533

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Factors associated with optimi ...... etic stem cell transplantation

@ast

Factors associated with optimi ...... etic stem cell transplantation

@en

type

Item

label

Factors associated with optimi ...... etic stem cell transplantation

@ast

Factors associated with optimi ...... etic stem cell transplantation

@en

prefLabel

Factors associated with optimi ...... etic stem cell transplantation

@ast

Factors associated with optimi ...... etic stem cell transplantation

@en

P1476

Factors associated with optimi ...... etic stem cell transplantation

@en

P2093

Allison R Butts

http://www.w3.org/2001/XMLSchema#string

Amy W Bryk

http://www.w3.org/2001/XMLSchema#string

Javier Bolaños-Meade

http://www.w3.org/2001/XMLSchema#string

Lauren D McBride

http://www.w3.org/2001/XMLSchema#string

Victoria T Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome

New advances in acute graft-versus-host disease prophylaxis.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

Alternative donor transplantation in acute myeloid leukemia: which source and when?

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.

P304

275-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155215577809

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25802301

http://www.w3.org/2001/XMLSchema#string

P932

4696901

http://www.w3.org/2001/XMLSchema#string